ADC Therapeutics SA at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Great. Good morning, everybody, and thanks for joining us for the next session. I'm Matthew Harrison, one of the biotech analysts here at Morgan Stanley. Very pleased to have ADC Therapeutics for the next session. Before we get started, I need to read a disclosure statement. Please note that all important disclosures including personal holdings disclosures and Morgan Stanley disclosures appear on the Morgan Stanley public website at morganstanley.com/researchdisclosures. So I'm pleased to have Jennifer Herron and Joseph Camardo with us this morning. Jennifer I'm going to turn it over to you to make some opening comments and then we'll jump into Q&A.
That's great. Thanks, Matthew. Good morning everyone and thanks for the opportunity to participate in the Morgan Stanley Healthcare Conference. It's an exciting time at ADC Therapeutics with our first commercial launch ongoing and the opportunity to
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
